General Information of the Compound
Compound ID |
CP0075426
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(-)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
Show/Hide
|
||||||||||||||||||
Synonyms |
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-timolol
Apo-Timol
Apo-Timol (TN)
Apo-Timop
Apo-Timop (TN)
Aquanil
Betim
Betimol
Betimol (TN)
Blocadren
Blocadren (TN)
Gen-Timolol (TN)
Istalol
Istalol (TN)
L-714,465
MK-950
Novo-Timol
Nu-Timolol
Nu-Timolol (TN)
Optimol
PMS-Timolol (TN)
Phoxal-timolol
Phoxal-timolol (TN)
Proflax
S(-)-Timolol maleate
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
TIM
Temserin
Tenopt
Tim-AK
Tim-AK (TN)
Timacar
Timolol
Timolol (INN)
Timolol (TN)
Timolol GFS
Timolol Maleate, (1:1) Salt
Timolol [USAN]
Timololum
Timololum [INN-Latin]
Timopic
Timoptic (TN)
Timoptic OcuDose
Timoptic OcuDose. (TN)
Timoptic-XE
Timoptic-XE (TN)
Timoptol
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C13H24N4O3S
|
||||||||||||||||||
Molecular Weight |
316.427
|
||||||||||||||||||
Canonical SMILES |
CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
BLJRIMJGRPQVNF-JTQLQIEISA-N
|
||||||||||||||||||
CAS |
131628-37-0
194288-09-0
26839-75-8
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02505, Beta-1 adrenergic receptor
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Clinical Information about the Compound